Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jul 24.
Published in final edited form as: Infect Control Hosp Epidemiol. 2015 Mar;36(3):350–352. doi: 10.1017/ice.2014.61

State Law Mandates for Reporting of Healthcare-Associated Clostridium difficile Infections in Hospitals

Julie Reagan 1, Carolyn TA Herzig 2, Monika Pogorzelska-Maziarz 3, Andrew W Dick 4, Patricia W Stone 2, JD Divya Srinath 5
PMCID: PMC4514439  NIHMSID: NIHMS701051  PMID: 25695178

Abstract

US state and territorial laws were reviewed to identify Clostridium difficile infection reporting mandates. Twenty states require reporting either under state law or by incorporating federal Centers for Medicare & Medicaid Services' reporting requirements. Although state law mandates are more common, the incorporation of federal reporting requirements has been increasing.


Most states have enacted laws and/or promulgated administrative regulations mandating data submission and public reporting of healthcare-associated infection (HAI) data.1 As part of this effort, many states have focused their efforts on the occurrence of healthcare-associated Clostridium difficile infections (CDI). The intent of our research was to review these state efforts.

The healthcare burden of CDI is alarming. A 2012 Centers for Disease Control and Prevention (CDC) report stated that the CDI incidence rates, mortality, and associated medical costs have reached historic highs.2 According to the CDC, the number of deaths attributable to CDI is estimated at 14,000 per year.2 Estimates of associated healthcare costs of hospital-onset CDI range from $5,042 to $7,179 per case with a national annual estimate of $897 million to $1.3 billion.3 Other cost estimates have been much higher.3

National reviews of reported CDI data indicate more work is needed to control the occurrence of CDI in hospitals. The National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination focuses on reducing the incidence of HAIs with a primary focus on 9 national targets.4 Both CDI hospitalizations and infections are national target measures reviewed under that plan on an annual basis.5 Compared with other HAI types, CDI reduction improvements have not been as forthcoming.5

The large burden of CDI as well as the realization that more work is needed to reduce the number of infections have directed attention to the need for stronger surveillance and prevention efforts. As a result, many states now mandate CDI data submission by hospitals as part of state HAI public reporting programs. CDI data are also collected on the federal level as part of the Centers for Medicare & Medicaid Services Hospital Inpatient Quality Reporting program. Under this program, CDI LabID Event reporting began in January 2013 for all acute care hospitals facility-wide using the National Healthcare Safety Network.6

We studied 4 components to determine the trend of CDI state reporting mandates: the number of states mandating CDI data submission by hospitals; progression over time; source of law (state law or federal requirements incorporated into the state law); and legal authority (statutory or administrative) used to impose the mandates.

Methods

HAI statutes and administrative regulations of the 50 US states, District of Columbia, and US territory of Puerto Rico as of July 1, 2013, were systematically reviewed. (For convenience, the term states will be used to refer to US states, District of Columbia, and Puerto Rico.) Legal research was conducted using Lexis Research System databases, online statutory compilations, and state administrative regulation databases. Queries consisted of variable CDI search terms: Clostridium difficile, C. difficile, C. diff., CDI, Clostridium difficile–associated disease, and CDAD. Additional state resources were reviewed to gather more detail about each state's CDI data submission mandates. In addition, state HAI coordinators (ie, state employees responsible for coordinating HAI surveillance and prevention efforts) were consulted to confirm the accuracy of the collected data or to provide missing data.

Results

Our results reveal that a minority of states mandate CDI data submission by hospitals. Table 1 demonstrates that, as of July 1, 2013, only 20 states mandate CDI data submission by hospitals.

Table 1. State Clostridium difficile infection (CDI) reporting mandates as of July 1, 2013.

Characteristic States Total
State does not mandate CDI data reporting AL, AK, AZ, CO, DC, FL, IA, ID, IN, KS, KY, LA, MA, MI, MO, MS, MT, ND, NE, NH, NJ, NV, OK, PR, SC, SD, TX, VA, VT, WA, WI, WY 32
State mandates CDI data reportinga AR, CA, CT, DE, GA, HI, IL, MD, ME, MN, NC, NM, NY, OH, OR, PA, RI, TN, UT, WV 20
Source of law
 Independent state mandate CA, IL, MD, ME, NM, NY, OH, OR, PA, RI, TN 11
 CMS IQR requirement incorporated into state law AR, CT, DE, GA, HI, MN, NC, UT, WV 9
Legal authority
 Statutory AR, CA, HI, IL, ME, UT 6
 Administrative CT, DE, GA, MD, MN, NC, NM, NY, OH, OR, PA, RI, TN, WV 14

Note. The term states here refers to US states, District of Columbia, and Puerto Rico. See the appendix for expansion of abbreviations. CMS IQR, Centers for Medicare & Medicaid Services Hospital Inpatient Quality Reporting program.

a

This has been updated from a previous report8 to include MD.

As shown in Table 2, CDI data submission state mandates have gradually increased from 2008 to 2013. The first effort began in 2008 with 2 states. Two states followed in 2009, 1 state in 2010, 1 state in 2011, and 4 states in 2012. The largest increase was made in the first half of 2013 with a total of 10 states.

Table 2. Effective dates of state Clostridium difficile infection data reporting requirements, by year, as of July 1, 2013.

Year States Total
2008 PA, OH 2
2009 CA, NY 2
2010 TN 1
2011 RI 1
2012 IL, ME, NM, OR 4
2013a AR, CT, DE, GA, HI, MD, MN, NC, UT, WV 10

Note. See the appendix for expansion of abbreviations.

a

This has been updated from a previous report8 to include MD.

Table 1 demonstrates that in 11 (55%) of the 20 states with reporting mandates, CDI reporting is independently mandated under state law. Alternatively, in the remaining 9 states (45%), CDI reporting is mandated by adoption or incorporation of the reporting requirements of the Centers for Medicare & Medicaid Services Inpatient Quality Reporting program into the state law.

States use 2 forms of legal authority for imposing CDI reporting mandates. As demonstrated by Table 1, 6 (30%) of the 20 states with reporting mandates specifically include the requirement in a state statute. The other 14 states (70%) require data submission through administrative mechanisms.

Discussion

States have begun to respond to the need for increased CDI surveillance in hospitals. Although only a minority of states throughout the nation mandate CDI data submission by hospitals, the number has steadily increased from 2008 to 2013. This increase was gradual up through 2012, with a marked jump in the first half of 2013. The increased use of CDI mandates throughout the nation will provide useful data for future studies used to determine the impact of reporting mandates on infection rates. Neither the consequences of the approaches to CDI reporting mandates nor the effects of the mandates themselves on CDI infection rates has been studied. As data are collected under state mandates, these areas will be ripe for future research.

The impact of federal guidance has clearly influenced state level CDI surveillance activities. It is likely that the increase in the number of states mandating CDI reporting in 2012 through July 2013 is partially due to the release of the CDC's CDI Report in early 2012.2 That report, along with other CDC guidance and technical support, directed much-needed attention to the healthcare burden of CDI.

State HAI program surveillance activities have also been heavily influenced by the federal Centers for Medicare & Medicaid Services Inpatient Quality Reporting program's CDI reporting requirements that became mandatory as of January 1, 2013. This impacted those states incorporating or adopting the Centers for Medicare & Medicaid Services Inpatient Quality Reporting program reporting requirements into their state laws. As it relates to CDI data submission mandates, this is significant because 9 of the 10 states that began reporting CDIs in 2013 did so under this state-federal mechanism.

CDI reporting mandates exist in both statutory and administrative forms. Statutory requirements provide the strongest legal authority for reporting mandates; however, only 6 states (30% of those mandating CDI data submission) have used this form. Alternatively, in many states CDI reporting mandates have not been directly presented in the state HAI statute but instead were added later in the form of an administrative regulation. Experts have expressed that general HAI statutes that contain provisions allowing for the addition of reporting requirements through administrative regulations are less burdensome and more flexible.7 Our study demonstrates that many states have chosen this less burdensome method. Of the 20 states mandating CDI reporting, most (14 states [70%]) use an administrative regulation or some other form of administrative requirement instead of a statutory provision.

We would be remiss in our presentation of data if we did not mention other state-level activities to prevent CDIs. Although some states have not mandated reporting of CDI, they have nevertheless taken other actions to reduce CDIs by implementing CDI prevention collaboratives with financial or technical support provided by the CDC.1 These state efforts reveal strong commitments to reduce or prevent CDIs regardless of the existence of a state legal mandate.

Acknowledgments

A previous analysis of CDI data, covering a shorter period (through January 31, 2013), was encompassed within a much broader analysis of state-mandated HAI reporting requirements (Herzig CT, Reagan J, Pogorzelska-Maziarz M, Srinath D, Stone PW. State-mandated reporting of health care-associated infections in the United States: trends over time. Am J Med Qual 2014; first published online June 20). This current study presents a more focused, updated, and extensive analysis specific to CDI.

Financial support. The National Institute of Nursing Research (grant R01NR010107); the Robert Wood Johnson Foundation as part of their Public Health Law Research Initiative through the Association of State and Territorial Health Officials (grant 270282) and the CDC (grant 400648).

Appendix. Appendix A. US state and territory abbreviations

AL, Alabama; AK, Alaska; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; PR, Puerto Rico; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

Footnotes

Potential conflict of interests: All authors report no conflicts of interest relevant to this article.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Nursing Research, National Institutes of Health, Centers for Disease Control and Prevention, or Association of State and Territorial Health Officials.

References

  • 1.Reagan J, Hacker C. Laws pertaining to healthcare-associated infections: a review of 3 legal requirements. Infect Control Hosp Epidemiol. 2012;33:75–80. doi: 10.1086/663204. [DOI] [PubMed] [Google Scholar]
  • 2.Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61:157–162. [PubMed] [Google Scholar]
  • 3.Walsh NC. C. difficile inpatient stays long, costly. [Accessed December 12, 2013.];MedPage Today. Available at: http://www.medpagetoday.com/MeetingCoverage/ASHP/36339. Published December 8, 2012.
  • 4.US Department of Health & Human Services. National action plan to prevent health care-associated infections: road map to elimination. [Accessed July 14, 2014]; Available at: http://www.hhs.gov/ash/initiatives/hai/actionplan/index.html.
  • 5.US Department of Health & Human Services. National action plan to prevent health care-associated infections: road map to elimination: national targets and metrics. [Accessed July 14, 2014]; Available at: http://www.health.gov/hai/prevent_hai.asp#hai_measures.
  • 6.Centers for Disease Control and Prevention, National Healthcare Safety Network. Operational guidance for acute care hospitals to report facility-wide inpatient (FacWideIN) Clostridium difficile infection (CDI) laboratory-identified (LabID) event data to CDC's NHSN for the purpose of fulfilling CMS's hospital inpatient quality reporting (IQR) requirements. [Accessed July 14, 2014]; http://www.cdc.gov/nhsn/PDFs/mrsa-cdi/FINAL-ACH-CDI-Guidance.pdf.
  • 7.Centers for Disease Control and Prevention, Association of State and Territorial Health Officials. Eliminating healthcare-associated infections: state policy options. [Accessed July 14, 2014];2011 Mar; Available at: http://www.cdc.gov/hai/pdfs/toolkits/toolkit-hai-policy-final_01-2012.pdf.
  • 8.Herzig CT, Reagan J, Pogorzelska-Maziarz M, Srinath D, Stone PW. State-mandated reporting of health care-associated infections in the United States: trends over time. Am J Med Qual. 2014 doi: 10.1177/1062860614540200. first published online June 20. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES